Abstract Progressive Myoclonus Epilepsy (PME) is a rare epilepsy syndrome characterized
by the development of progressively worsening myoclonus, ataxia, and seizures. A …

The progressive myoclonus epilepsies (PME) are a diverse group of disorders that feature
both myoclonus and seizures that worsen gradually over a variable timeframe. While each of …

The progressive myoclonic epilepsies (PMEs) are a group of symptomatic generalised
epilepsies caused by rare disorders, most of which have a genetic component, a debilitating …

Background Progressive myoclonic epilepsy (PME) is a group of neurodegenerative
diseases with genetic heterogeneity and phenotypic similarities, and many cases remain …

ABSTRACT Introduction: Progressive myoclonus epilepsies (PMEs) constitute a rare and
heterogeneous group of genetic disorders with a distinctive triad of myoclonus, seizures …

Background The progressive myoclonic epilepsies (PMEs) are a disparate group of
syndromes whose common features include disabling myoclonus, progressive cognitive …

The progressive myoclonic epilepsies (PMEs) are a devastating group of rare disorders1
that manifest with increasing action myoclonus, which is also present at rest but activates …

The progressive myoclonic epilepsies (PME) are a rare group of inherited
neurodegenerative diseases with debilitating evolution, resistance to treatment and poor …

It has been estimated that JME (juvenile myoclonic epilepsy), when compared to other adult
epilepsy syndromes, is most likely to have a genetic cause. However, decades of research …

Progressive myoclonus epilepsies (PMEs) comprise a group of clinically and genetically
heterogeneous rare diseases. Over 70% of PME cases can now be molecularly solved …